Skip to content
New to DAT Supply? Create a client account to view pricing, order samples and start your first order.
DAT Supply Log in
Navigation
Profile

Preferences

Choose your market — it sets your site and language.

Start order

Already a member? Log in

How dosage and actives affect supplement format choice

How dosage and actives affect supplement format choice

When developing a private-label supplement, the choice of format—whether capsule, tablet, powder, or liquid—depends heavily on the active ingredients and their required dosage. High-dose actives may suit powders or liquids, while low-dose or sensitive compounds often perform better in capsules or tablets. This guide helps brand owners understand how to match their formulation goals with the right delivery format, working within a flexible private-label framework that prioritizes safety, compliance, and market readiness.

What this format is and who it suits

A supplement format refers to the physical delivery system—such as capsules, tablets, powders, or softgels—each with distinct advantages. Capsules are ideal for powders or oils, tablets for compressed ingredients, and powders for high-dose blends. This format suits brand owners who have identified their target actives and dosage levels, and need guidance on which format best preserves stability, bioavailability, and consumer convenience.

Choosing actives and a category fit

The active ingredients and their dosage drive format selection. For example, high-dose vitamin C or magnesium may work better as powders, while low-dose or bitter actives are often encapsulated. Category fit also matters: sports nutrition often uses powders, while general wellness favors capsules or tablets. Brand owners should prepare a list of desired actives and target dosages to discuss with their manufacturing partner.

Personalisation: Make it Yours

DAT Supply’s Make it Yours program allows brand owners to customize existing formulations by adjusting actives, dosages, or excipients within pre-validated ranges. This approach balances flexibility with regulatory safety, as base formulations have already been tested for stability and compatibility. Brand owners can select from a menu of options to create a unique product without starting from scratch.

Documentation and responsibilities

Brand owners are responsible for final product claims, labels, and market compliance. DAT Supply provides formulation documentation, certificates of analysis for raw materials, and stability data as applicable. However, it is the brand owner’s duty to ensure that the finished product meets all local regulations, including labeling requirements and permitted health claims.

From samples to production

Once a format and formulation are agreed upon, DAT Supply produces samples for evaluation. After approval, the project moves to full-scale production. The timeline depends on raw material availability, formulation complexity, and order quantity. Brand owners can request samples to test stability, taste, and consumer appeal before committing to a larger run.

How this format fits a multi-format range

Offering multiple formats—capsules, tablets, powders, liquids—allows brand owners to cater to different consumer preferences and dosage needs. A single active ingredient can be delivered in various formats, expanding market reach. DAT Supply supports multi-format ranges by providing consistent quality across all delivery systems, enabling brand owners to build a cohesive product line.

Continue exploring

Where to next?

Browse the reviewed catalogue, request samples, or start an order when you're ready — the DAT Supply portal routes your brief through the right review step.

Quick context request

Get manufacturing context

Drop your work email and a member of the DAT team will follow up with the right context for this concept. Order documents, certificates and pricing are released through the client workspace in the DAT portal.

You will receive a short confirmation email. Order documents (specification, batch-specific COA, packaging documents) are released through the client workspace in the DAT portal once a brief is in place.

/usr/bin/bash: line 5: /tmp/hermes-snap-51302552d562.sh: No such file or directory /usr/bin/bash: line 6: /tmp/hermes-cwd-51302552d562.txt: No such file or directory